Structure | Chemical Name | CAS | MF |
|
5-(METHOXYCARBONYL)-2-BROMOPHENYLBORONIC ACID
|
2225178-33-4
|
C8H8BBrO4
|
|
2-Trifluoromethyl-4-(pyrrolidino)phenylboronic acid
|
2225178-40-3
|
C11H13BF3NO2
|
|
1-(3-Trifluoromethylphenyl)-1H-pyrazole-4-boronic acid
|
2225178-71-0
|
C10H8BF3N2O2
|
|
2-Fluoro-4-(cyclopentyl)phenylboronic acid
|
2225178-77-6
|
C11H14BFO2
|
|
2-Cyano-4-morpholinophenylboronic acid
|
2225179-08-6
|
C11H13BN2O3
|
|
3-Bromo-5-(methoxymethyl)phenylboronic acid
|
2225179-17-7
|
C8H10BBrO3
|
|
2-Methoxy-4-(piperidin-1-yl)phenylboronic acid
|
2225179-31-5
|
C12H18BNO3
|
|
(6-CYANO-2-METHYLPYRIDIN-3-YL)BORONIC ACID
|
2225180-00-5
|
C7H7BN2O2
|
|
2-Bromo-6-methylpyridine-4-boronic acid
|
2225181-29-1
|
C6H7BBrNO2
|
|
2-Chloro-4-(morpholino)phenylboronic acid
|
2225181-64-4
|
C10H13BClNO3
|
|
methyl (2E)-4-amino-4-methylpent-2-enoate hydrochloride
|
2225181-78-0
|
C7H14ClNO2
|
|
4,9-Dibromo-2,7-di(2,5,8,11,14,17,20-heptaoxadocosan-22-yl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone
|
2225708-89-2
|
C44H64Br2N2O18
|
|
FT-895)
|
2225728-57-2
|
C16H15F3N4O2
|
|
(R)-(1,4-Dibenzylpiperazin-2-yl)methanol dihydrochloride
|
2225787-90-4
|
C19H25ClN2O
|
|
Piperazine, 2-(chloromethyl)-1,4-bis(phenylmethyl)-, (2R)-
|
2225787-91-5
|
C19H23ClN2
|
|
2-Piperazineacetonitrile, 1,4-bis(phenylmethyl)-, (2S)-
|
2225787-92-6
|
C20H23N3
|
|
Benzamide, 3-[4-(aminocarbonyl)phenoxy]-
|
2225800-19-9
|
C14H12N2O3
|
|
N,N-Bis(4-methoxyphenyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-amine
|
2225806-07-3
|
C30H32BNO4
|
|
tert-butyl 2-imino-2-oxo-2lambda6-thia-6-azaspiro[3.3]heptane-6-carboxylate
|
2225816-09-9
|
C10H18N2O3S
|
|
BAY-2402234
|
2225819-06-5
|
C21H18ClF5N4O4
|
|
YTX-465
|
2225824-53-1
|
C25H26N6O3
|
|
3,3',3''-(1,3,5-triazine-2,4,6-triyl)triphenol
|
2225834-22-8
|
C21H15N3O3
|
|
Acetamide, N-[2-(5-chloro-2,6-dimethoxy-1H-benzimidazol-1-yl)ethyl]-
|
2225836-30-4
|
C13H16ClN3O3
|
|
1-Dibenzofuranamine, N-(9,9-dimethyl-9H-fluoren-2-yl)-
|
2225845-23-6
|
C27H21NO
|
|
3-Bromofuran-2-5-diboronic acid pinacol ester
|
2225873-46-9
|
C16H25B2BrO5
|
|
7-Quinolinamine, 3-methoxy-
|
2225878-56-6
|
C10H10N2O
|
|
1-Isoquinolinecarboxylic acid, 4-fluoro-
|
2225878-70-4
|
C10H6FNO2
|
|
1-Isoquinolinecarboxylic acid, 6-(trifluoromethyl)-
|
2225878-86-2
|
C11H6F3NO2
|
|
(3S)-6-BROMO-2,3-DIHYDROBENZO[B]FURAN-3-YLAMINE HYDROCHLORIDE
|
2225878-88-4
|
C8H9BrClNO
|
|
1(2H)-Isoquinolinone, 4-fluoro-6-(trifluoromethyl)-
|
2225879-23-0
|
C10H5F4NO
|
|
5-bromo-6-fluoroisoquinolin-3-amine
|
2225879-49-0
|
C9H6BrFN2
|
|
EGFR-IN-5
|
2225887-26-1
|
C31H38FN9O
|
|
4,4',4",4"'-(pyrene-1,3,6,8-tetrayl)tetrakis(2-aminobenzoic acid)
|
2225888-66-2
|
C44H30N4O8
|
|
4,4',4",4"'-(pyrene-1,3,6,8-tetrayl)tetrakis(3-aminobenzoic acid)
|
2225892-57-7
|
C44H30N4O8
|
|
ATX inhibitor 1
|
2225892-70-4
|
C21H23Cl2N2O6P
|
|
CMP3a
|
2225902-88-3
|
C28H27F3N6O2S
|
|
PEG9-Bis-t-butyl ester
|
2225903-62-6
|
C30H58O13
|
|
4,7,10,13,16,19,22,25,28,31,34,37,40-Tridecaoxatritetracontanedioic acid
|
2225903-66-0
|
C30H58O17
|
|
8-bromo-1-chlorodibenzo[b,d]furan
|
2225909-61-3
|
C12H6BrClO
|
|
MS1943
|
2225938-17-8
|
C42H54N8O3
|
|
β-Alanine, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-
|
2225940-46-3
|
C16H15N3O6
|
|
Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
|
2225940-47-4
|
C17H17N3O6
|
|
Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
|
2225940-48-5
|
C18H19N3O6
|
|
6-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]hexanoic acid
|
2225940-49-6
|
C19H21N3O6
|
|
Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
|
2225940-50-9
|
C20H23N3O6
|
|
Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-
|
2225940-51-0
|
C21H25N3O6
|
|
E3 Ligase Ligand-Linker Conjugates 22
|
2225940-52-1
|
C23H32N4O8
|
|
Spiro[9H-fluorene-9,9'-[9H]xanthene], 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
2225963-98-2
|
C31H27BO3
|
|
Dabigatran Etexilate Impurity 8
|
2225986-94-5
|
C34H41N7O5
|
|
Dabigatran iMpurity K
|
2225986-95-6
|
C34H41N7O5
|
|
Dibenzofuran, 4-iodo-6-phenyl-
|
2226031-12-3
|
C18H11IO
|
|
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
2226086-11-7
|
C30H26F2O5
|
|
2,6-Naphthalenedicarboxylic acid, 4,8-diamino-
|
2226204-96-0
|
C12H10N2O4
|
|
CHLOROPHENARSAZENE
|
2226215-36-5
|
C113H92N4O4
|
|
9H-Fluorene, 2-bromo-5,9,9-triphenyl-
|
2226234-90-6
|
C31H21Br
|
|
N-PEG3-N'-(azide-PEG3)-Cy5
|
2226235-96-5
|
C39H54ClN5O6
|
|
Bisoprolol IMpurity
|
2226263-67-6
|
C18H31NO4
|
|
Bisoprolol Impurity
|
2226263-68-7
|
C18H31NO4
|
|
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-(2-propyn-1-yloxy)-
|
2226303-74-6
|
C16H12N2O5
|
|
Methy1 1-amino-3-(benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylate
|
2226366-36-3
|
C14H14N2O4
|
|
(S)-N-[1-(Dimethylamino)-3-phenyl-2-propyl]acetamide
|
2226371-98-6
|
C13H20N2O
|
|
2-Bromo-4,8-bis((2-octyldodecyl)oxy)benzo[1,2-b:4,5-b']dithiophene
|
2226388-08-3
|
C50H85BrO2S2
|
|
Photoswitchable PAD Inhibitor (technical grade)
|
2226393-62-8
|
C26H26ClN7O
|
|
Rosuvastatin Impurity 89
|
2226413-61-0
|
C38H46F2N6O9S2
|
|
Rosuvastatin Impurity 90
|
2226413-62-1
|
C38H44F2N6O8S2
|
|
5-(1-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-2-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
2226428-25-5
|
C24H28N2O3
|
|
1-Bromo-3-chloro-4-fluoro-2-iodobenzene
|
2226439-58-1
|
C6H2BrClFI
|
|
C8-IDTT-CHO
|
2226449-53-0
|
C54H74O2S4
|
|
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-ethyl 5-(1-methylethyl) ester
|
2226462-72-0
|
C20H24N2O6
|
|
Stannane, 1,1'-[4,8-bis[5-[(2-ethylhexyl)thio]-4-fluoro-2-thienyl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]bis[1,1,1-trimethyl-
|
2226464-70-4
|
C40H56F2S6Sn2
|
|
5-([2,2':6',2''-terpyridin]-4'-yl)isophthalic acid
|
2226465-62-7
|
C23H15N3O4
|
|
DBCO-PEG4-Val-Cit-PAB-PNP
|
2226472-28-0
|
C55H66N8O15
|
|
2'-O-(2-Cyanoethyl)adenosine
|
2226475-42-7
|
C12H16N8O4
|
|
BDP 9066)
|
2226507-04-4
|
C20H24N6
|
|
SGC-GAK-1
|
2226517-76-4
|
C18H17BrN2O3
|
|
FM479
|
2226521-64-6
|
C25H26N6O2
|
|
FM-381
|
2226521-65-7
|
C24H24N6O2
|
|
Y06137
|
2226534-49-0
|
C27H32N4O2
|
|
Lipid 8
|
2226547-25-5
|
C44H82N2O2
|
|
t-Boc-Aminooxy-PEG7-amine
|
2226611-29-4
|
C21H44N2O10
|
|
(4-chlorophenyl)(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone
|
2226649-85-8
|
C19H20BClO3
|
|
(2-Bromo-4-methylphenyl)(2-chloro-4-fluorophenyl)methanone
|
2226650-44-6
|
C14H9BrClFO
|
|
[2-Bromo-4-[(ethylsulfonyl)methyl]phenyl](2-chloro-4-fluorophenyl)methanone
|
2226650-47-9
|
C16H13BrClFO3S
|
|
2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro-
|
2226664-93-1
|
C17H11Cl2N3O2
|
|
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
2-methyl- L-Norleucine
|
2226710-38-7
|
C22H25NO4
|
|
Amino-PEG24-alcohol
|
2226726-55-0
|
C48H99NO24
|
|
Mal-PEG24-NHS ester
|
2226733-37-3
|
C62H111N3O31
|
|
GSK547
|
2226735-55-1
|
C20H18F2N6O
|
|
5-Chlorobiphenyl-2-boronic Acid
|
2226739-30-4
|
C12H10BClO2
|
|
9H-Fluoren-2-amine, N-[1,1'-biphenyl]-4-yl-9,9-dimethyl-N-[3-(9-phenyl-9H-fluoren-9-yl)phenyl]-
|
2226747-62-0
|
C52H39N
|
|
1,3,5-Triazine, 2-[1,1'-biphenyl]-3-yl-4-chloro-6-(3-dibenzofuranyl)-
|
2226747-73-3
|
C27H16ClN3O
|
|
Tilvestamab
|
2226775-26-2
|
|
|
Cyclobutanamine, 2-methoxy-, hydrochloride (1:1), (1R,2R)-rel-
|
2226828-67-5
|
C5H12ClNO
|
|
1,3,4,9-TETRAHYDRO-B-CARBOLINE-2-CARBOXYLIC ACID METHYL ESTER HCL
|
2226840-20-4
|
C13H17ClN2O2
|
|
HOOCCH2CH2-PEG16-CH2CH2COOH
|
2226897-74-9
|
C38H74O21
|
|
1-Dibenzofuranol, 7-chloro-
|
2226916-90-9
|
C12H7ClO2
|
|
4',4'''-(phenylazanediyl)bis(([1,1'-biphenyl]-3,5-dicarboxylic acid))
|
2226923-73-3
|
C34H23NO8
|
|
Aurora inhibitor 1
|
2227019-45-4
|
C23H25N9S
|
|
NPT200-11
|
2227057-23-8
|
|
|
2227064-46-0
|
2227064-46-0
|
C53H58N6O6
|